SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation has launched the second in a line of nanofluidic chips — digital arrays — run on the BioMark™ system for qPCR analysis. Digital arrays have been validated as a breakthrough for applications that require absolute counting of target molecules, often within samples as small as a single cell. The method of choice to achieve such quantification is known as digital PCR, which has been too impractical for routine use until now.
